PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver cirrhosis |
| Phenotype | C0019212|hepatorenal syndrome |
| Sentences | 6 |
| PubMedID- 25983746 | Treatment of hepatorenal syndrome (hrs) in patients with liver cirrhosis is still challenging and characterized by a very high mortality. |
| PubMedID- 21484118 | Cystatin c: a predictor of hepatorenal syndrome in patients with liver cirrhosis. |
| PubMedID- 22924265 | Diagnostical significance of dimethylarginine in the development of hepatorenal syndrome in patients with alcoholic liver cirrhosis. |
| PubMedID- 23788898 | Secondary to hbv or hcv) accompanied by intensive regenerative processes,patients with adenocarcinoma metastases into the liver,liver cirrhosis complicated by hepatorenal syndrome,non-alcoholic fatty liver disease,renal failure. |
| PubMedID- 20124895 | Purpose of review: the development of hepatorenal syndrome in liver cirrhosis leads to an increased morbidity and mortality in patients with cirrhosis. |
| PubMedID- 22094211 | hepatorenal syndrome occurs in patients with advanced liver cirrhosis and is associated with functional renal impairment and poor prognosis. |
Page: 1